Shineway Pharmaceutical Declares RMB 0.85 Special Interim Dividend for FY 2026

Bulletin Express

Sep 18

China Shineway Pharmaceutical Group Limited announced a special interim dividend of RMB 0.85 per ordinary share for the financial year ending 31 December 2026. Based on an exchange rate of RMB 1 to HKD 1.171, shareholders on the Hong Kong register will receive an equivalent cash distribution of HKD 0.995 per share.

The ex-dividend date is set for 02 October 2026. Shareholders must lodge transfer documents with Computershare Hong Kong Investor Services Limited by 16:30 on 05 October 2026 to qualify for the payout. The share register will be closed from 06 to 07 October 2026, with 07 October 2026 designated as the record date. Dividend cheques are scheduled for dispatch on 15 October 2026.

This dividend does not require separate shareholder approval and is classified as an ordinary distribution. No withholding tax implications or related warrant or convertible security issues were reported. The board currently comprises Executive Directors Li Zhenjiang, Xin Yunxia, and Li Huimin; Non-executive Director Zhou Wencheng; and Independent Non-executive Directors Liu Shun Fai, Yew Yat On, and Wang Guihua.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1187736759"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1187736759\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1187736759?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-18 12:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187736759","market":"us","top_or_hot":-1,"title":"Shineway Pharmaceutical Declares RMB 0.85 Special Interim Dividend for FY 2026","media":"Bulletin Express","content":"<p>China Shineway Pharmaceutical Group Limited announced a special interim dividend of RMB 0.85 per ordinary share for the financial year ending 31 December 2026. Based on an exchange rate of RMB 1 to HKD 1.171, shareholders on the Hong Kong register will receive an equivalent cash distribution of HKD 0.995 per share.</p>\n<p>The ex-dividend date is set for 02 October 2026. Shareholders must lodge transfer documents with Computershare Hong Kong Investor Services Limited by 16:30 on 05 October 2026 to qualify for the payout. The share register will be closed from 06 to 07 October 2026, with 07 October 2026 designated as the record date. Dividend cheques are scheduled for dispatch on 15 October 2026.</p>\n<p>This dividend does not require separate shareholder approval and is classified as an ordinary distribution. No withholding tax implications or related warrant or convertible security issues were reported. The board currently comprises Executive Directors Li Zhenjiang, Xin Yunxia, and Li Huimin; Non-executive Director Zhou Wencheng; and Independent Non-executive Directors Liu Shun Fai, Yew Yat On, and Wang Guihua.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shineway Pharmaceutical Declares RMB 0.85 Special Interim Dividend for FY 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShineway Pharmaceutical Declares RMB 0.85 Special Interim Dividend for FY 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-18 12:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Shineway Pharmaceutical Group Limited announced a special interim dividend of RMB 0.85 per ordinary share for the financial year ending 31 December 2026. Based on an exchange rate of RMB 1 to HKD 1.171, shareholders on the Hong Kong register will receive an equivalent cash distribution of HKD 0.995 per share.</p>\n<p>The ex-dividend date is set for 02 October 2026. Shareholders must lodge transfer documents with Computershare Hong Kong Investor Services Limited by 16:30 on 05 October 2026 to qualify for the payout. The share register will be closed from 06 to 07 October 2026, with 07 October 2026 designated as the record date. Dividend cheques are scheduled for dispatch on 15 October 2026.</p>\n<p>This dividend does not require separate shareholder approval and is classified as an ordinary distribution. No withholding tax implications or related warrant or convertible security issues were reported. The board currently comprises Executive Directors Li Zhenjiang, Xin Yunxia, and Li Huimin; Non-executive Director Zhou Wencheng; and Independent Non-executive Directors Liu Shun Fai, Yew Yat On, and Wang Guihua.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02877","symbol_name":"神威药业","start_time":0,"source_url":"","article_id":"1187736759","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187736759","pubTimestamp":1789705305,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Shineway Pharmaceutical Group Limited announced a special interim dividend of RMB 0.85 per ordinary share for the financial year ending 31 December 2026. Based on an exchange rate of RMB 1 to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02877":"神威药业"},"translate_title":"神威药业宣派2026财年特别中期股息0.85元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02877":1},"content_text":"China Shineway Pharmaceutical Group Limited announced a special interim dividend of RMB 0.85 per ordinary share for the financial year ending 31 December 2026. Based on an exchange rate of RMB 1 to HKD 1.171, shareholders on the Hong Kong register will receive an equivalent cash distribution of HKD 0.995 per share.\nThe ex-dividend date is set for 02 October 2026. Shareholders must lodge transfer documents with Computershare Hong Kong Investor Services Limited by 16:30 on 05 October 2026 to qualify for the payout. The share register will be closed from 06 to 07 October 2026, with 07 October 2026 designated as the record date. Dividend cheques are scheduled for dispatch on 15 October 2026.\nThis dividend does not require separate shareholder approval and is classified as an ordinary distribution. No withholding tax implications or related warrant or convertible security issues were reported. The board currently comprises Executive Directors Li Zhenjiang, Xin Yunxia, and Li Huimin; Non-executive Director Zhou Wencheng; and Independent Non-executive Directors Liu Shun Fai, Yew Yat On, and Wang Guihua.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}